You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

human parainfluenza vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Metapneumovirus and Human Parainfluenza Infection Trial in United States (mRNA-1653, Placebo)

Completed
  • Human Metapneumovirus and Human Parainfluenza Infection
  • mRNA-1653
  • Placebo
  • Birmingham, Alabama
  • +18 more
Feb 2, 2023

SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

Recruiting
  • SARS-CoV-2 Infection
  • B/HPIV3/S-6P
  • Baltimore, Maryland
    Johns Hopkins Bloomberg School of Public Health
Aug 30, 2023

Ebola Virus Disease Trial in Baltimore (HPIV3/?HNF/EbovZ GP vaccine, Placebo)

Suspended
  • Ebola Virus Disease
  • HPIV3/ΔHNF/EbovZ GP vaccine
  • Placebo
  • Baltimore, Maryland
  • +1 more
Mar 2, 2022

Influenza, Human Trial in Brisbane (ARCT-2138, Licensed Quadrivalent Vaccine for younger adults, Licensed Quadrivalent Vaccine

Not yet recruiting
  • Influenza, Human
  • ARCT-2138
  • +2 more
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane Clinic
Nov 8, 2023

Rabies Vaccine Adverse Reaction Trial in Changsha (Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose

Completed
  • Rabies Vaccine Adverse Reaction
  • Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose program
  • +3 more
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Oct 9, 2023

Rabies Trial in Xiangyang (Rabies Vaccine(Human Diploid Cell)for Human Use,Freeze-dried)

Not yet recruiting
  • Rabies
  • Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried
  • Xiangyang, Hubei, China
    Gucheng Center for Disease Control and Prevention
Nov 19, 2023

Human Metapneumovirus and Human Parainfluenza Infection Trial in Omaha, Austin, Fort Worth (mRNA-1653, Placebo)

Completed
  • Human Metapneumovirus and Human Parainfluenza Infection
  • mRNA-1653
  • Placebo
  • Omaha, Nebraska
  • +2 more
Feb 5, 2020

Influenza, Human Trial (sa-mRNA vaccine Dose 1, sa-mRNA vaccine Dose 2, sa-mRNA vaccine Dose 3)

Not yet recruiting
  • Influenza, Human
  • sa-mRNA vaccine Dose 1
  • +4 more
  • (no location specified)
Sep 7, 2023

Human Papillomavirus Infection Trial in United States (Laboratory Biomarker Analysis, Questionnaire Administration, Recombinant

Active, not recruiting
  • Human Papillomavirus Infection
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +5 more
Jan 26, 2023

Norovirus Infections, Norwalk Gastroenteritis Trial (Human Norovirus Bivalent (G?.1/G?.4)Vaccine,Recombinant (Hansenula

Not yet recruiting
  • Norovirus Infections
  • Norwalk Gastroenteritis
  • Human Norovirus Bivalent (GⅠ.1/GⅡ.4)Vaccine，Recombinant (Hansenula polymorpha)
  • placebo
  • (no location specified)
Jun 14, 2023

Yellow Fever Trial in Leiden (Yellow Fever Vaccine)

Recruiting
  • Yellow Fever
  • Yellow Fever Vaccine
  • Leiden, Netherlands
    Leiden University Medical Center
Jun 12, 2023

Human Papilloma Virus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papilloma Virus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant Quadrivalent Human Papillomavirus (Types 6,11,16,18) Vaccine (Saccharomyces cerevisiae)
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)

Not yet recruiting
  • Human Papillomavirus-Related Carcinoma
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +4 more
Aug 9, 2023

Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus Trial in Rolling Hills Estates, Miami,

Recruiting
  • Respiratory Syncytial Virus Infection
  • +2 more
  • RSV/hMPV vaccine candidate Dose L
  • +3 more
  • Rolling Hills Estates, California
  • +2 more
Nov 14, 2023

Cytomegalovirus Infections Trial in Manchester (SPYVAC01)

Not yet recruiting
  • Cytomegalovirus Infections
  • SPYVAC01
  • Manchester, United Kingdom
    Medicines Evaluation Unit
Nov 20, 2023

Rabies Vaccine Adverse Reaction, Safety and Efficacy Trial in Changsha (Freeze-dried human rabies vaccine (Vero cells)

Recruiting
  • Rabies Vaccine Adverse Reaction
  • Safety and Efficacy
  • Freeze-dried human rabies vaccine (Vero cells) Zhifeilongkoma - 5-dose program
  • +3 more
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Sep 21, 2022

Cervical Carcinoma, Human Papillomavirus Infection Trial in Liberia (Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis

Enrolling by invitation
  • Cervical Carcinoma
  • Human Papillomavirus Infection
  • Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed
  • +3 more
  • Liberia, Guanacaste, Costa Rica
    Agencia Costarricense de Investigaciones Biomédicas - Fundación
Aug 11, 2022

Coronavirus Trial (OVX033, Saline solution)

Not yet recruiting
  • Coronavirus
  • OVX033
  • Saline solution
  • (no location specified)
Nov 14, 2023

Human Papillomavirus Infection Trial in Nanjing (Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus

Completed
  • Human Papillomavirus Infection
  • Recombinant Nonavalent (Types 6/11/16/18/31/33/45/52/58) Human Papillomavirus (HPV) Vaccine (Escherichia Coli)
  • Recombinant nonavalent Human Papillomavirus (Types 6,11,16,18,31,33,45,52,58) Vaccine
  • Nanjing, Jiangsu, China
    CDC, Jiangsu Province
Jan 12, 2023

Rabies Trial in China (5-dose group of test vaccine, 5-dose group of control vaccine, 4-dose A group of test vaccine)

Not yet recruiting
  • Rabies
  • 5-dose group of test vaccine
  • +3 more
  • Chengdu, Sichuan, China
  • +3 more
Jul 23, 2023

Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
  • Edegem, Belgium
    Antwerp University Hospital
Jul 19, 2023

Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)

Not yet recruiting
  • Human Papillomavirus Infection
  • Human papillomavirus (HPV) Vaccine
  • Placebo
  • Canberra, Australia
    Paratus Clinical Research Canberra
Jan 4, 2023

Head and Neck Carcinoma, Adult Disease Trial in Villejuif (HPVDC injection level dose 1, injection level dose 1, HPVDC

Recruiting
  • Head and Neck Carcinoma
  • Adult Disease
  • HPVDC injection level dose 1
  • +3 more
  • Villejuif, France
    Gustave Roussy
Aug 17, 2023

High Grade Anal Canal Intraepithelial Neoplasia, High Grade Vulvar Squamous Intraepithelial Lesion Trial in Birmingham, Seattle

Terminated
  • High Grade Anal Canal Intraepithelial Neoplasia
  • High Grade Vulvar Squamous Intraepithelial Lesion
  • Laboratory Biomarker Analysis
  • +3 more
  • Birmingham, Alabama
  • +1 more
Jan 24, 2023

Covid19 Trial in United States (CVXGA1 low dose, CVXGA1 high dose)

Recruiting
  • Covid19
  • CVXGA1 low dose
  • CVXGA1 high dose
  • Bardstown, Kentucky
  • +3 more
Aug 16, 2022